Tectonic Therapeutic Gross Profit

The latest gross profit for TECX is $0 as of June 2026. That compares with $-340K in the prior-year period — up 100.0% year over year. That is below the sector sector average of $740M. Investors often review this figure alongside Tectonic Therapeutic's historical trend and sector peers before judging valuation or financial health.

Over the past year, TECX's gross profit moved from $-340K to $0 — a 100.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tectonic Therapeutic's operating scale or balance-sheet position.

Against its sector companies, TECX currently prints $0 for gross profit, while the sector average sits near $740M. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Tectonic Therapeutic's growth, margins, and balance sheet.

A gross profit figure of $0 for TECX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $740M. Explore the charts below for those layers of context.

After noting TECX's gross profit ($0), review year-over-year change from $-340K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.